Gene · 60674
Papers4,548
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 4,548
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| HSPB1 Orchestrates the Inflammation-Associated Transcriptome Profile of Atherosclerosis in HUVECs. | Front Biosci (Landmark Ed) | 2025 | 40018940 | PubTator, text mining | PubMed |
| Screening and Validation of Potential Biomarkers of Immune Cells in Childhood Asthma Patients via Mendelian Randomization and Machine Learning. | J Inflamm Res | 2025 | 40008080 | PubTator, text mining | PubMed |
| The Multifaceted Role of lncRNA GAS5: A Pan-Cancer Analysis of Its Diagnostic, Prognostic, and Therapeutic Potential. | Cureus | 2025 | 39958058 | PubTator, text mining | PubMed |
| Targeting the lncRNA GAS5/TLR4/NLRP3 signaling cascade inhibits endometrial stromal cell pyroptosis and prevents the progression of intrauterine adhesions. | J Reprod Immunol | 2025 | 39951898 | PubTator, text mining | PubMed |
| SNORD80-guided 2'-O-methylation stabilizes the lncRNA GAS5 to regulate cellular stress responses. | Proc Natl Acad Sci U S A | 2025 | 39946530 | PubTator, text mining | PubMed |
| Long Non-Coding RNAs in Ovarian Cancer: Mechanistic Insights and Clinical Applications. | Cancers (Basel) | 2025 | 39941838 | PubTator, text mining | PubMed |
| Epigenetic Regulation by lncRNA GAS5/miRNA/mRNA Network in Human Diseases. | Int J Mol Sci | 2025 | 39941145 | PubTator, text mining | PubMed |
| Aberrant SNHG expression predicts poor prognosis in esophageal cancer using meta-analysis and bioinformatics analysis. | BMC Gastroenterol | 2025 | 39920577 | PubTator, text mining | PubMed |
| Fabrication, characterization, and application of gelatin/alginate-based hydrogels incorporating selenium-doped deferoxamine-derived carbon quantum dots: In vitro and in vivo studies. | Int J Biol Macromol | 2025 | 39909275 | PubTator, text mining | PubMed |
| Retraction Note: Long noncoding RNA GAS5 inhibits malignant proliferation and chemotherapy resistance to doxorubicin in bladder transitional cell carcinoma. | Cancer Chemother Pharmacol | 2025 | 39899159 | PubTator, text mining | PubMed |
| The regulatory role and therapeutic potential of long non-coding RNA in non-small cell lung cancer. | J Cancer | 2025 | 39895777 | PubTator, text mining | PubMed |
| LncRNA GAS5 reduces blood glucose levels and alleviates renal fibrosis in diabetic nephropathy by regulating the miR-542-3p/ERBB4 axis. | Diabetol Metab Syndr | 2025 | 39849629 | PubTator, text mining | PubMed |
| Plasma Humanin and Non-Coding RNAs as Biomarkers of Endothelial Dysfunction in Rheumatoid Arthritis: A Pilot Study. | Noncoding RNA | 2025 | 39846683 | PubTator, text mining | PubMed |
| In silico analysis of lncRNA-miRNA-mRNA signatures related to Sorafenib effectiveness in liver cancer cells. | World J Gastroenterol | 2025 | 39839902 | PubTator, text mining | PubMed |
| m6A-modified lncRNA GAS5 promotes M1-polarization of microglia in alcohol use disorder. | Brain Res Bull | 2025 | 39828042 | PubTator, text mining | PubMed |
| Natural products and long non-coding RNAs in prostate cancer: insights into etiology and treatment resistance. | Naunyn Schmiedebergs Arch Pharmacol | 2025 | 39825964 | PubTator, text mining | PubMed |
| Epigenetic Role of Long Non-coding RNAs in Multiple Myeloma. | Curr Oncol Rep | 2025 | 39776330 | PubTator, text mining | PubMed |
| From diagnosis to therapy: The role of LncRNA GAS5 in combatting some cancers affecting women. | Gene | 2025 | 39756550 | PubTator, text mining | PubMed |
| Dysregulation of GAS5-miRNA-Mediated Signaling Pathways in Cancer Pathobiology: A Comprehensive Exploration of Pathways Influenced by this Axis. | Biochem Genet | 2025 | 39718723 | PubTator, text mining | PubMed |
| GAS5 long non-coding RNA interacts with microRNA-205 to relieve fibroblast-like synoviocyte inflammation and ferroptosis in osteoarthritis. | Apoptosis | 2025 | 39644356 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/60674/papers?page=9